4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kamada Ltd. (KMDA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Rehovot, Israel with about 462 employees. Its market capitalization is roughly $407 million. In the fiscal year ended 2025-12-31, KMDA reported $180M in revenue and $20M in net income.
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics.
Interactive charts & full statements → Open the KMDA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $180M | $161M | $142M | $129M | — |
| Gross Profit | $76M | $70M | $56M | $47M | — |
| Operating Income (EBIT) | $26M | $20M | $10M | $4M | — |
| Net Income | $20M | $14M | $8M | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $45M | $45M | $47M | $45M | $44M | — |
| Gross Profit | $19M | $17M | $20M | $19M | $21M | — |
| Operating Income (EBIT) | $7M | $4M | $8M | $7M | $8M | — |
| Net Income | $4M | $4M | $5M | $7M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($12M) | $0M | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | ($12M) | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $379M | $372M | $355M | $322M | — |
| Total Liabilities | $110M | $113M | $111M | $146M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KMDA viewer.
About TickerBase · Data methodology & sources